Consistent Export Growth: 12.40% CAGR Over 7 Years
India's exports under HSN Chapter 30 have grown at a compound annual rate of 12.40% over 7 fiscal years, rising from ₹1,03,239.93 Crore in FY 2018-19 to ₹2,08,128.62 Crore in FY 2024-25.
30 HSN Code: Pharmaceutical Products
HSN Chapter 30 represents Pharmaceutical Products under GST classification. This code helps businesses identify Pharmaceutical Products correctly for billing, taxation, and trade purposes. With HSN Chapter 30, companies can avoid errors in invoices, simplify compliance, and enable hassle-free import/export of Pharmaceutical Products.
Live Demo Available Today
Experience the power of Expert Accounting
Join our guided walkthrough to see how BUSY can transform your business operations.
Trusted by 6,00,000+ Users
4.6 Google Rating
Sub-chapters under HSN Chapter 30
Following Sub Chapters fall under Pharmaceutical Products:
Sub Chapter
New GST Rate
Old GST Rate
Description
Sub Chapter
New GST Rate
18
%
Standard
Old GST Rate
5
%
Description
Glands and other organs for organotherapeutic uses, dried,whether or not powdered; extracts of glands or other organs or of their secretions for organotherapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included
Sub Chapter
New GST Rate
5
%
Essential
Old GST Rate
12
%
Description
Human blood; animal blood prepared fortherapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines,toxins, cultures of micro-organisms (excluding yeasts) and ether similar products; cell cultures, whether or not modified
Sub Chapter
New GST Rate
5
%
Essential
Old GST Rate
12
%
Description
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
Sub Chapter
New GST Rate
5
%
Essential
Old GST Rate
12
%
Description
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
Sub Chapter
New GST Rate
5
%
Essential
Old GST Rate
5
%
Description
Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes
Sub Chapter
New GST Rate
5
%
Essential
Old GST Rate
5
%
Description
Pharmaceutical goods specified in note 4 to this chapter
India’s Trade Performance — HSN Chapter 30 in FY 2024-25
TradeStat EIDB — Ministry of Commerce & Industry
FY 2018-19–FY 2024-25
Values in ₹ Crore
India’s Exports
FY 2024-25₹2,08,129 Cr
+13.70%
vs FY 2023-24
5.6199% of India’s total exports
India’s Imports
FY 2024-25₹25,225 Cr
+17.86%
vs FY 2023-24
0.4136% of India’s total imports
Trade Balance
FY 2024-25₹1,82,904 Cr
Trade Surplus
Surplus rank #1 of 97 chapters
At a glance
12.40%
Export CAGR
FY 2018-19 → FY 2024-25 · 7 fiscal years
#5
National Export Rank
of 97 chapters by export value, FY 2024-25
+24.48%
Peak Growth Year
FY 2020-21 · strongest single-year move
2×
Export Growth · 7Y
₹1,03,239.93 Cr → ₹2,08,128.62 Cr
India Export-Import Trade Statistics for HSN Chapter 30
7-year export and import data, FY 2018-19 to FY 2024-25, in ₹ Crore. Source: Ministry of Commerce & Industry, TradeStat EIDB.
FY 2018-19
Exp. Rank #6
Balance
+88,658.80
Exports
1,03,239.93 ₹ Cr
4.4757% share
— YoY
Imports
14,581.13 ₹ Cr
0.4057% share
— YoY
FY 2019-20
Exp. Rank #6
Balance
+98,942.66
Exports
1,15,473.03 ₹ Cr
5.2051% share
+11.85% YoY
Imports
16,530.37 ₹ Cr
0.4919% share
+13.37% YoY
FY 2020-21
Exp. Rank #3
Balance
+1,24,804.03
Exports
1,43,738.39 ₹ Cr
6.6599% share
+24.48% YoY
Imports
18,934.36 ₹ Cr
0.6494% share
+14.54% YoY
FY 2021-22
Exp. Rank #8
Balance
+1,18,977.90
Exports
1,44,580.86 ₹ Cr
4.5950% share
+0.59% YoY
Imports
25,602.96 ₹ Cr
0.5599% share
+35.22% YoY
FY 2022-23
Exp. Rank #7
Balance
+1,38,620.82
Exports
1,59,643.65 ₹ Cr
4.4092% share
+10.42% YoY
Imports
21,022.83 ₹ Cr
0.3656% share
−17.89% YoY
FY 2023-24
Exp. Rank #5
Balance
+1,61,648.86
Exports
1,83,051.61 ₹ Cr
5.0592% share
+14.66% YoY
Imports
21,402.75 ₹ Cr
0.3811% share
+1.81% YoY
FY 2024-25
Exp. Rank #5
Balance
+1,82,904.08
Exports
2,08,128.62 ₹ Cr
5.6199% share
+13.70% YoY
Imports
25,224.54 ₹ Cr
0.4136% share
+17.86% YoY
CAGR · 7-Year
Exports
12.40% /yr
Imports
9.57% /yr
Consistently Surplus
Peak export growth year
Latest available data
Not available
YoY = change vs previous FY
Key Trade Insights: HSN Chapter 30 Export-Import Analysis
HSN Chapter 30 Ranked #5 Among All 97 Chapters by Export Value
In FY 2024-25, HSN Chapter 30 ranks #5 out of 97 chapters by total export value. By trade surplus, it ranks #1 of 97.
FY 2020-21 Was the Strongest Growth Year for HSN Chapter 30 Exports
The strongest single-year export movement for HSN Chapter 30 was recorded in FY 2020-21, when exports surged by 24.48% over the prior year.
India Maintains a Trade Surplus of ₹1,82,904.08 Crore in HSN Chapter 30 Goods
In FY 2024-25, India's exports of ₹2,08,128.62 Cr exceeded imports of ₹25,224.54 Cr, resulting in a trade surplus of ₹1,82,904.08 Crore — ranking #1 of 97 by surplus magnitude.
Import Growth of 9.57% CAGR Signals Stable Import Dependency for Pharmaceutical Products
India's imports under HSN Chapter 30 have grown at 9.57% CAGR, reaching ₹25,224.54 Crore in FY 2024-25.
Stop worrying about
HSN & TAX compliance
BUSY auto-applies the correct HSN codes & GST rates, ensuring 100% error-free billing every single time.
Automatic Updates
Error-free GSTR
6,00,000+ Happy Users
Important Disclaimer
The above does not constitute professional advice or a formal recommendation. We recommend consulting a professional tax consultant before acting on the information contained in this piece of content.